Copied


Anthropic Stock Price Prediction: Heavy post-filing growth meets a stretched, oversold tape

Peter Zhang   Nov 17, 2026 19:05 0 Min Read


IPO filings put the growth story front and center

Anthropic’s latest amended IPO filing changed the market’s framing by giving investors a fuller look at the business. CNBC reported on November 2, 2026 that Anthropic generated $33.24 billion in revenue for the nine months ended Sept. 30, up roughly 1,200% from the same period a year earlier, alongside a $104 billion net loss over that span. Reuters, via Investing.com on November 10, said the company plans to raise as much as $64.4 billion in a U.S. IPO and is targeting a valuation of up to $1.02 trillion based on outstanding shares disclosed in the filing. CNBC also said the company filed to offer 825 million shares at $70 to $78 apiece, which would imply up to a $1.405 trillion fully diluted valuation.

That combination matters because it creates a simple tension: the revenue line is scaling fast, but the cost base is still enormous. For equity investors, the market is not just pricing growth; it is pricing confidence that growth can persist long enough to absorb the expense structure.

The tape is weak, but not structurally broken

ANTHROPIC stock is trading at $1,252.52, down 6.01% over 24 hours, after moving between $1,340.50 and $1,221.37. The setup is clearly bearish on trend: the 7-day SMA at $1,332.29 sits below the 20-day SMA at $1,473.29, which in turn is below the 50-day SMA at $1,765.44. Price is also below the 12-day EMA at $1,377.78 and the 26-day EMA at $1,522.30.

At the same time, momentum is stretched. The 14-day RSI is 23.73, which is in oversold territory, and the Stochastic readings are equally depressed at 6.73 for %K and 5.38 for %D. That does not guarantee a bounce, but it does say the market has already done a lot of selling in a short window.

The broader location is still important. Price is only modestly above the pivot point at $1,271.46 and not far above immediate support at $1,202.43, with stronger support at $1,152.33. The Bollinger lower band sits at $1,134.53, and the %B reading of 0.1741 places the stock near lower-band support. In plain terms: the trend is weak, but the market is extended enough that reflex rallies are plausible if selling pressure eases.

Volume and derivatives point to a pause, not a panic

The volume-price regime is listed at 0.43x versus the 5-day average, which suggests this is more of a low-volume pullback than a full capitulation move. That matters because breakage through support is usually more meaningful when volume expands; here, the tape looks heavy, but not disorderly.

Binance perpetual futures funding is neutral at 0.0050%. That tells you positioning is not aggressively skewed in one direction on that venue. It does not establish broader shareholder conviction, but it does suggest the futures market is not flashing a crowded consensus trade.

What would change the setup

The bullish read from here is a technical mean-reversion bounce rather than a clean trend reversal. For that to gain credibility, Anthropic would need to reclaim the pivot area and then push back toward the immediate resistance band at $1,321.56 and the 7-day moving average at $1,332.29. A move through that zone would reduce near-term downside pressure.

The bearish read is straightforward: if $1,202.43 fails, the chart opens a path toward $1,152.33, with the Bollinger lower band at $1,134.53 acting as the next technical reference. In that case, the market would be signaling that the recent oversold condition is not yet enough to stabilize price.

The next major fundamental catalyst is the IPO process itself, but the exact timing is still fluid in the evidence provided. CNBC said the company planned to price shares on Nov. 18 and begin trading the following day, while Yahoo Finance reported the IPO was expected on either Nov. 19 or Nov. 20. That date window is the key near-term catalyst, because it will test whether investors are willing to accept a still-loss-making growth story at a very large valuation.


Read More